← All Sponsors
SPONSOR

Odyssey Therapeutics

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Ulcerative Colitis (UC)UC - Ulcerative Colitis
NCT06850727 Phase 2
Recruiting

Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC)
Australia, Austria, Canada View Trial →